Patent ID: 11865118
Assignee: MUTABILIS
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 6:
7. The compound of claim 1 selected from the group consisting of:
[2-(2-aminoethylcarbamoyl)-5,8-methano-6-oxo-4,8-dihydrothiazolo[4,5-e][1,3]diazepin-7-yl]sulfonic acid;
[2-(guanidinomethyl)-5,8-methano-6-oxo-4,8-dihydrothiazolo[4,5-e][1,3]diazepin-7-yl]sulfonic acid;
[2-(2-guanidinoethylcarbamoyl)-5,8-methano-6-oxo-4,8-dihydrothiazolo[4,5-e][1,3]diazepin-7-yl]sulfonic acid;
[trans-4-(dimethylcarbamoyl)-2-(2-guanidinoethylcarbamoyl)-5,8-methano-6-oxo-4,8-dihydrothiazolo[4,5-e][1,3]diazepin-7-yl] hydrogen sulfate;
[N-[[trans-4-(dimethylcarbamoyl)-5,8-methano-6-oxo-7-sulfooxy-4,8-dihydrothieno[2,3-e][1,3]diazepin-3-yl]methyl]carbamimidoyl]ammonium 2,2,2- trifluoroacetate;
[(trans-4-(dimethylcarbamoyl)-3-(2-guanidinoethyl)-5,8-methano-6-oxo-4,8-dihydrothieno[2,3-e][1,3]diazepin-7-yl] hydrogen sulfate.